查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1485862

奈米技术药物传输市场，按技术类型、管理模式、应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Nanotechnology Drug Delivery Market, By Technology Type, By Mode of Administration, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年奈米技术药物输送市场规模为891.9843亿美元，2024年至2032年复合年增长率为9.81%。

奈米技术药物传输市场-市场动态

慢性病发病率上升推动对先进奈米技术药物传输解决方案的需求

全球慢性病发病率不断上升，推动了对先进奈米技术药物传输解决方案的需求。例如，根据世界卫生组织 (WHO) 的数据，非传染性疾病 (NCD) 约占全球死亡人数的 71%，其中心血管疾病、癌症、呼吸系统疾病和糖尿病是主要原因。为了应对这项健康挑战，美国国立卫生研究院 (NIH) 等组织越来越多地投资于奈米医学研究，以开发能够有效治疗慢性病同时最大限度减少副作用的标靶药物输送系统。此外，辉瑞和诺华等製药公司正在积极探索基于奈米技术的药物传输平台，以提高慢性病治疗的效果和患者的依从性。对创新药物输送解决方案的日益重视凸显了透过奈米技术进步解决慢性疾病负担的迫切需求。

奈米技术药物传输市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 9.81% 左右的复合年增长率成长

根据技术类型细分，预计奈米粒子将在 2023 年显示最大的市场份额

依给药方式细分，2023年静脉给药为主导类型

按地区划分，北美是 2023 年的主要收入来源

奈米技术药物传输市场-細項分析：

全球奈米技术药物传输市场根据技术类型、管理模式、应用和区域进行细分。

根据技术类型，市场分为五类：奈米晶体、奈米粒子、脂质体、胶束和树枝状聚合物。由于奈米颗粒在靶向药物传输方面的多功能性和有效性，已成为奈米技术药物传输市场的主导技术类型。透过精确控制尺寸和表面特性，奈米颗粒可提供增强的稳定性、生物相容性和治疗有效负载能力，从而推动其更高的市场采用率。

根据给药方式，市场分为四类：口服、静脉注射、经皮和吸入。静脉给药因其直接进入全身循环且起效快而成为奈米技术给药市场的主要模式。这种模式可以精确控制药物输送，使其适合需要立即治疗介入的危急医疗状况。

奈米技术药物传输市场 - 地理洞察

北美由于强大的研究基础设施以及对医疗保健和奈米技术的高投资而引领市场，安进公司和强生等公司开创了创新的药物输送系统。在欧洲，瑞士和英国等国家正在见证重大进步，罗氏控股公司和阿斯特捷利康公司等公司投资于基于奈米技术的解决方案。与此同时，以印度和日本为首的亚太地区在医疗保健支出增加和慢性病患病率上升的推动下正在经历快速增长。 Sun Pharmaceutical Industries Ltd 和 Takeda Pharmaceutical Company Limited 等地区企业正在利用奈米技术开发客製化的药物输送系统。

奈米技术药物输送市场-竞争格局：

安进公司、强生公司等领先公司约翰逊、罗氏控股公司和阿斯特捷利康公司处于领先地位，在研发方面进行了大量投资，以创新基于奈米技术的新型药物输送系统。这些公司专注于开发有针对性的高效药物传输平台，以改善治疗效果和患者依从性。此外，策略合作、伙伴关係和收购是市场参与者为加强产品组合和扩大地理影响力而采用的常见策略。例如，2022年，全球製药公司辉瑞宣布与专门从事奈米医学的生物技术公司BIND Therapeutics合作。此次合作旨在利用 BIND 的 Accurin 技术（一种利用奈米颗粒的靶向药物传输平台）来增强辉瑞肿瘤治疗药物的传输。这种伙伴关係促进了新型癌症治疗方法的开发，提高了疗效并减少了副作用。新创企业和新创公司也透过引入颠覆性技术和利基药物输送解决方案来提高市场竞争力。

最近的发展：

2021年9月，Nanovis宣布推出首款也是唯一一款生物陶瓷奈米管增强椎弓根螺钉系统nano fortifix(R)，展示了一款开创性的奈米技术增强椎弓根螺钉系统，标籤声称可增强骨骼生长

2020 年 7 月，Curadigm 宣布从 BPI France 的 Deep Tech Program 获得 100 万欧元资金，以支持 Nanoprimer 平台的开发，强调对其 Nanoprimer 技术进行大量投资，以提高各种药物类别的治疗生物利用度和功效

目录

第一章：奈米技术药物传输市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按技术类型分類的奈米技术药物传输市场片段
    • 按管理模式分類的奈米技术药物传输市场片段
    • 奈米技术药物传输市场片段（按应用）
    • 按国家/地区分類的奈米技术药物传输市场片段
    • 按地区分類的奈米技术药物传输市场片段
  • 竞争洞察

第 3 章：奈米技术药物传输主要市场趋势

  • 奈米技术药物传输市场驱动因素
    • 市场驱动因素的影响分析
  • 奈米技术药物传输市场的限制
    • 市场限制影响分析
  • 奈米技术药物输送市场机会
  • 奈米技术药物传输市场未来趋势

第 4 章：奈米技术药物传输产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：奈米技术药物输送市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：奈米技术药物传输市场格局

  • 2023 年奈米技术药物传输市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：奈米技术药物传输市场 - 按技术类型

  • 概述
    • 按技术类型分類的细分市场份额分析
    • 奈米晶体
    • 奈米粒子
    • 脂质体
    • 胶束
    • 树枝状聚合物
    • 其他的

第 8 章：奈米技术药物传输市场 - 按给药模式

  • 概述
    • 按管理模式分類的细分市场占有率分析
    • 口服
    • 静脉
    • 透皮
    • 吸入
    • 其他的

第 9 章：奈米技术药物传输市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 肿瘤学
    • 心血管疾病
    • 神经病学
    • 抗发炎/免疫学
    • 抗感染
    • 其他的

第 10 章：奈米技术药物传输市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美奈米技术药物传输主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按技术类型）
    • 北美市场规模与预测（按管理模式）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲奈米技术药物传输主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按技术类型）
    • 欧洲市场规模与预测（按管理模式）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区奈米技术药物传输主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依技术类型）
    • 亚太地区市场规模与预测（依管理模式）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲奈米技术药物传输主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按技术类型）
    • 拉丁美洲市场规模与预测（按管理模式）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲奈米技术药物传输主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（依技术类型）
    • 中东和非洲市场规模及预测（依管理模式）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 奈米技术药物输送产业

  • 竞争仪表板
  • 公司简介
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Celator Pharmaceuticals Inc
    • Celgene Corporation
    • Celsion Corporation
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Nanobiotix SA
    • Novartis International AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2766

REPORT HIGHLIGHT

Nanotechnology Drug Delivery Market size was valued at USD 89,198.43 Million in 2023, expanding at a CAGR of 9.81% from 2024 to 2032.

The Nanotechnology Drug Delivery Market, leveraging nanoscale materials for targeted and efficient drug delivery, is poised for significant growth. The potential for enhanced drug efficacy and reduced side effects, increasing investments in nanomedicine research, and the rising prevalence of chronic diseases demanding novel therapeutic solutions drive market growth. However, market growth is restrained by challenges such as regulatory complexities, concerns regarding toxicity and biocompatibility, and high research and development costs. Opportunities lie in the development of novel nanocarriers for gene therapy, personalized medicine, and the utilization of nanotechnology for overcoming biological barriers, thereby expanding the scope of drug delivery applications.

Nanotechnology Drug Delivery Market- Market Dynamics

Rising Chronic Disease Rates Propel Demand for Advanced Nanotechnology Drug Delivery Solutions

The escalating rates of chronic diseases worldwide are driving the demand for advanced nanotechnology drug delivery solutions. For instance, according to the World Health Organization (WHO), non-communicable diseases (NCDs) account for approximately 71% of all deaths globally, with cardiovascular diseases, cancer, respiratory diseases, and diabetes being the leading causes. In response to this health challenge, organizations like the National Institutes of Health (NIH) in the United States are increasingly investing in nanomedicine research to develop targeted drug delivery systems that can effectively treat chronic conditions while minimizing side effects. Additionally, pharmaceutical companies such as Pfizer and Novartis are actively exploring nanotechnology-based drug delivery platforms to enhance therapeutic outcomes and patient compliance in the treatment of chronic diseases. This growing emphasis on innovative drug delivery solutions underscores the urgent need to address the burden of chronic illnesses through nanotechnology advancements.

Nanotechnology Drug Delivery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.81% over the forecast period (2024-2032)

Based on Technology Type segmentation, Nanoparticles were predicted to show maximum market share in the year 2023

Based on Mode of Administration segmentation, Intravenous was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanotechnology Drug Delivery Market- Segmentation Analysis:

The Global Nanotechnology Drug Delivery Market is segmented on the basis of Technology Type, Mode of Administration, Application, and Region.

The market is divided into five categories based on Technology Type: Nanocrystals, Nanoparticles, Liposomes, Micelles, and Dendrimers. Nanoparticles have emerged as the dominant technology type in the Nanotechnology Drug Delivery Market due to their versatility and effectiveness in targeted drug delivery. With precise control over size and surface properties, nanoparticles offer enhanced stability, biocompatibility, and therapeutic payload capacity, driving their higher market adoption.

The market is divided into four categories based on the Mode of Administration: Oral, Intravenous, Transdermal, and Inhalation. Intravenous administration stands out as the primary mode in the Nanotechnology Drug Delivery Market, owing to its direct access to systemic circulation and rapid onset of action. This mode offers precise control over drug delivery, making it suitable for critical medical conditions requiring immediate therapeutic intervention.

Nanotechnology Drug Delivery Market- Geographical Insights

North America leads the market due to robust research infrastructure and high investments in healthcare and nanotechnology, with players like Amgen Inc. and Johnson & Johnson pioneering innovative drug delivery systems. In Europe, countries like Switzerland and the United Kingdom are witnessing significant advancements, with companies such as Roche Holding AG and AstraZeneca PLC investing in nanotechnology-based solutions. Meanwhile, the Asia Pacific region, led by India and Japan, is experiencing rapid growth fueled by increasing healthcare expenditure and rising chronic disease prevalence. Regional players like Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited are leveraging nanotechnology to develop tailored drug delivery systems.

Nanotechnology Drug Delivery Market- Competitive Landscape:

Leading companies such as Amgen Inc., Johnson & amp; Johnson, Roche Holding AG, and AstraZeneca PLC are at the forefront, investing significantly in research and development to innovate novel nanotechnology-based drug delivery systems. These companies focus on developing targeted and efficient drug delivery platforms to improve therapeutic outcomes and patient compliance. Additionally, strategic collaborations, partnerships, and acquisitions are common strategies employed by market players to strengthen their product portfolios and expand their geographic presence. For instance, in 2022, Pfizer, a global pharmaceutical company, announced a collaboration with BIND Therapeutics, a biotechnology company specializing in nanomedicine. The collaboration aimed to utilize BIND's Accurin technology, a targeted drug delivery platform utilizing nanoparticles, to enhance the delivery of Pfizer's oncology therapeutics. This partnership facilitated the development of novel cancer treatments with improved efficacy and reduced side effects. Emerging players and startups are also contributing to market competitiveness by introducing disruptive technologies and niche drug delivery solutions.

Recent Developments:

In September 2021, Nanovis announced the launch of the first and only bioceramic nanotube-enhanced pedicle screw system, nano fortifix(R), showcasing a pioneering nanotechnology-enhanced pedicle screw system with label claims to enhance bone growth

In July 2020, Curadigm Announces EUR 1 million in funding from BPI France's Deep Tech Program to Support the Development of the Nanoprimer Platform, highlighting a substantial investment in their Nanoprimer technology to enhance therapeutic bioavailability and efficacy across various drug classes

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Amgen Inc.

AstraZeneca plc

Bristol-Myers Squibb Company

Celator Pharmaceuticals Inc

Celgene Corporation

Celsion Corporation

GlaxoSmithKline plc

Johnson & Johnson

Merck & Co., Inc.

Nanobiotix S.A.

Novartis International AG

Pfizer Inc.

Roche Holding AG

Sanofi S.A.

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanocrystals
  • Nanoparticles
  • Liposomes
  • Micelles
  • Dendrimers
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Intravenous
  • Transdermal
  • Inhalation
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Neurology
  • Anti-inflammatory/Immunology
  • Anti-infective
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanotechnology Drug Delivery Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanotechnology Drug Delivery Market Snippet by Technology Type
    • 2.1.2.Nanotechnology Drug Delivery Market Snippet by Mode of Administration
    • 2.1.3.Nanotechnology Drug Delivery Market Snippet by Application
    • 2.1.4.Nanotechnology Drug Delivery Market Snippet by Country
    • 2.1.5.Nanotechnology Drug Delivery Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanotechnology Drug Delivery Key Market Trends

  • 3.1.Nanotechnology Drug Delivery Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanotechnology Drug Delivery Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanotechnology Drug Delivery Market Opportunities
  • 3.4.Nanotechnology Drug Delivery Market Future Trends

4.Nanotechnology Drug Delivery Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanotechnology Drug Delivery Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanotechnology Drug Delivery Market Landscape

  • 6.1.Nanotechnology Drug Delivery Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanotechnology Drug Delivery Market - By Technology Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Technology Type, 2023 & 2032 (%)
    • 7.1.2.Nanocrystals
    • 7.1.3.Nanoparticles
    • 7.1.4.Liposomes
    • 7.1.5.Micelles
    • 7.1.6.Dendrimers
    • 7.1.7.Others

8.Nanotechnology Drug Delivery Market - By Mode of Administration

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
    • 8.1.2.Oral
    • 8.1.3.Intravenous
    • 8.1.4.Transdermal
    • 8.1.5.Inhalation
    • 8.1.6.Others

9.Nanotechnology Drug Delivery Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Cardiovascular Diseases
    • 9.1.4.Neurology
    • 9.1.5.Anti-inflammatory/Immunology
    • 9.1.6.Anti-infective
    • 9.1.7.Others

10.Nanotechnology Drug Delivery Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Nanotechnology Drug Delivery Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Nanotechnology Drug Delivery Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Nanotechnology Drug Delivery Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Nanotechnology Drug Delivery Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Nanotechnology Drug Delivery Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Nanotechnology Drug Delivery Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.AbbVie Inc.
    • 11.2.2.Amgen Inc.
    • 11.2.3.AstraZeneca plc
    • 11.2.4.Bristol-Myers Squibb Company
    • 11.2.5.Celator Pharmaceuticals Inc
    • 11.2.6.Celgene Corporation
    • 11.2.7.Celsion Corporation
    • 11.2.8.GlaxoSmithKline plc
    • 11.2.9.Johnson & Johnson
    • 11.2.10.Merck & Co., Inc.
    • 11.2.11.Nanobiotix S.A.
    • 11.2.12.Novartis International AG
    • 11.2.13.Pfizer Inc.
    • 11.2.14.Roche Holding AG
    • 11.2.15.Sanofi S.A.
    • 11.2.16.Teva Pharmaceutical Industries Ltd.
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanotechnology Drug Delivery Market: Technology Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology Type
  • TABLE Global Nanotechnology Drug Delivery Market, by Technology Type 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Mode of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mode of Administration
  • TABLE Global Nanotechnology Drug Delivery Market, by Mode of Administration 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanotechnology Drug Delivery Market, by Application 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanotechnology Drug Delivery Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)